What M&A critics don't understand about drug innovation
The Federal Trade Commission just announced plans to "take an aggressive approach to tackling anticompetitive pharmaceutical mergers." Kelly Slaughter, the acting head of the agenc…
The Federal Trade Commission just announced plans to "take an aggressive approach to tackling anticompetitive pharmaceutical mergers." Kelly Slaughter, the acting head of the agenc…